3.52
0.41%
-0.0146
시간 외 거래:
3.52
전일 마감가:
$3.5346
열려 있는:
$3.5
하루 거래량:
1,308
Relative Volume:
0.13
시가총액:
$3.00M
수익:
-
순이익/손실:
$-9.29M
주가수익비율:
-0.6769
EPS:
-5.2
순현금흐름:
$-9.42M
1주 성능:
-0.62%
1개월 성능:
+4.64%
6개월 성능:
-18.07%
1년 성능:
-26.51%
Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Company Profile
명칭
Scinai Immunotherapeutics Ltd Adr
전화
972-8-9302529
주소
JERUSALEM BIOPARK, 2ND FLOOR, JERUSALEM
SCNI을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
SCNI
Scinai Immunotherapeutics Ltd Adr
|
3.52 | 3.00M | 0 | -9.29M | -9.42M | -5.20 |
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 112.90B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 75.06B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
665.68 | 40.45B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.75B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
120.88 | 28.98B | 3.30B | -501.07M | 1.03B | -2.1146 |
Scinai Immunotherapeutics Ltd Adr 주식(SCNI)의 최신 뉴스
Scinai Immunotherapeutics (NASDAQ: SCNI) Expands CDMO Operations with New U.S. Subsidiary - Barchart
Scinai Immunotherapeutics (NASDAQ: SCNI) Announces Strategic Board Appointment - Barchart
Scinai Immunotherapeutics (NASDAQ: SCNI) Welcomes Dr. Jonathan Sadeh to Scientific Advisory Board - Barchart
Scinai Immunotherapeutics (NASDAQ: SCNI) Reports Nine-Month Financial Results - Barchart
Scinai Immunotherapeutics (NASDAQ: SCNI) to Spotlight I&I Pipeline, CDMO Services at BIO-Europe 2024 - Barchart
Scinai Regains Full Compliance with Nasdaq Listing Requirements - Benzinga
Scinai secures $2 million investment commitment By Investing.com - Investing.com India
Scinai reports promising psoriasis treatment study - Investing.com
Scinai reports Q1 results, progresses in pipeline By Investing.com - Investing.com South Africa
Scinai Immunotherapeutics enacts reverse split to meet Nasdaq rules - Investing.com
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Scinai Immunotherapeutics Ltd Adr (SCNI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):